Mcl1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MCL1 Protein | |
|---|---|
| Protein Name | MCL1 |
| Gene | MCL1 |
| UniProt ID | Q07820 |
| PDB ID | 2JM5, 4G35, 5JSB |
| Molecular Weight | 37 kDa (long isoform) |
| Subcellular Localization | Mitochondria, ER |
| Protein Family | BCL2 family |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
MCL1 is a 37 kDa protein with BH1, BH2, BH3, and BH4 domains. Unlike other anti-apoptotic BCL2 proteins, MCL1 has an extended N-terminal region with multiple PEST sequences (regions rich in Proline, Glutamic acid, Serine, Threonine) that target it for rapid degradation. MCL1 has a short half-life (~30 minutes) making it highly regulated.
MCL1 is an anti-apoptotic protein with unique characteristics:
In neurons, MCL1 provides critical neuroprotection, particularly for motor neurons in ALS.
| Disease | Role | Mechanism |
|---|---|---|
| ALS | Neuroprotective | Reduced MCL1 in motor neurons |
| Alzheimer's Disease | Impaired | Altered regulation |
| Cancer | Oncogenic | Frequently amplified/overexpressed |
The study of Mcl1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.